CoChat

Silencing of T Lymphocytes by Antigen-Driven Programmed Death in Recombinant Adeno-Associated Virus Vector-Mediated Gene Therapy

Open access

The DOI matches its Crossref record; 52 of the 53 references it cites were found in a registry or an index.

Abstract

Recombinant adeno-associated virus (rAAV) vectors are considered promising for human gene replacement because they facilitate stable expression of therapeutic proteins in transduced tissues. Whether the success of gene therapy will be influenced by cellular immune responses targeting transgene-encoded proteins that are potentially immunogenic is unknown. Here we characterized CD8+ T-cell activity against β-galactosidase and enhanced green fluorescent protein, model antigens containing major histocompatibility complex (MHC) class I epitopes that are constitutively produced in murine skeletal muscle after rAAV vector transduction. Antigen-specific CD8+ T cells were detected in the spleen and liver of mice within 7 days of muscle transduction. CD8+ T-cell frequencies in these organs were stable, and effector functions were intact for months despite ongoing antigen production in muscle. CD8+ T cells also infiltrated transduced muscle, where frequencies were at least 5-fold higher than in untransduced spleen and liver. Significantly, the majority of antigen-specific CD8+ T cells in vector-transduced muscle were not functional. Loss of function in the muscle was associated with programmed death of the effector cells. Stable gene expression therefore depended on selective death of CD8+ T cells at the site of antigen production, an effective mechanism for subverting immunity that is also potentially reversible.

Overview

Integrity signals

Registry

Crossref · 10.1182/blood-2008-01-131375

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 52 references

Cited by

See all 47

Metadata

Authors
Velazquez, V. M., Bowen, D. G., & Walker, C. M.
Affiliations
Nationwide Children's Hospital (US)
Venue
Blood
Published
2009-01-15
Volume
113
Issue
3
Pages
538-545
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W1971494439
Cited by
46
References
53
Citations by year
2025: 1 · 2024: 3 · 2023: 1 · 2022: 1 · 2021: 2 · 2019: 3 · 2018: 1 · 2017: 4 · 2016: 1 · 2015: 3 · 2014: 4 · 2013: 7 · 2012: 1
FWCI
2.67
Type
journal article
Language
en
Open access
Locations
  • Blood (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • Medical Research Council
  • National Health and Medical Research Council
  • National Institute of Allergy and Infectious Diseases (F31AI68609-2, 5R01-AI06388-5, F31AI068609)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
Keywords
recombinant adeno-associated virus vectors, gene therapy, CD8+ T cells, programmed cell death, antigen-specific T cell responses, MHC class I epitopes, skeletal muscle transduction, beta-galactosidase, enhanced green fluorescent protein, immune evasion
MeSH terms
Dependovirus, Animals, beta-Galactosidase, Enzyme-Linked Immunosorbent Assay, Flow Cytometry, Genetic Vectors, Humans, Lymphocyte Activation, Mice, Inbred BALB C, Mice, Inbred C57BL, Phenotype, Promoter Regions, Genetic, Transduction, Genetic, Genetic Therapy, Apoptosis, CD8-Positive T-Lymphocytes, Muscle, Skeletal, Green Fluorescent Proteins, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Silencing of T Lymphocytes by Antigen-Driven Programmed Death in Recombinant Adeno-Associated Virus Vector-Mediated Gene Therapy. https://app.cochat.ai/papers/10.1182/blood-2008-01-131375
The paper
Velazquez, V. M., Bowen, D. G., & Walker, C. M. (2009). Silencing of T Lymphocytes by Antigen-Driven Programmed Death in Recombinant Adeno-Associated Virus Vector-Mediated Gene Therapy. Blood. https://doi.org/10.1182/blood-2008-01-131375

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.